Changes in the pattern of oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis during therapy with beta interferons, and glatiramer acetate respectively. Pilot study;Změny vzorce oligoklonálních proužků v likvoru nemocných s roztroušenou sklerózou během terapie interferony beta, resp. glatiramer acetátem. Pilotní studie

Ceska a Slovenska Neurologie a Neurochirurgie

Volumn 66, Issue 2, 2003, Pages 118-120

  Mares J ^a   Muchova B ^a   Herzig, R ^a   Urbanek K ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Beta interferon; Cerebrospinal fluid; Glatiramer acetate; Multiple sclerosis; Oligoclonal bands

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; CLADRIBINE; COPAXON; GLATIRAMER; INTERFERON BETA SERINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOMODULATION; ISOELECTRIC FOCUSING; MALE; MEDICAL INFORMATION; MEDICAL LITERATURE; MULTIPLE SCLEROSIS;

EID: 17544392440     PISSN: 12107859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Havrdová E, a kol. Neuroimunologie. Praha: Maxdorf Jessenius; 2000. p. 451.
2. Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J Neuroimmunol 1999; 93(1-2): 8-14.
3. Kaiser R, Obert M, Kaufmann R, Czygan M. IgG-antibodies to CNS proteins in patients with multiple sclerosis. Eur J Med Res 1997; 2(4): 169-72.
4. Antel JP, Birnbaum G, Hartung HP. Clinical neuroimunology. London: Blackwell Science; 1998. p. 423.
5. Confavreux C, Chapuis-Cellier C, Arnaud P, Robert O, Aimard G, Devic M. Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon. J Neurol Neurosurg Psychiatry 1986; 49(11): 1308-12.
6. Kinnunen E, Timonen T, Pirttila T, Kalliomaki P, Ketonen L, Matikainen E, et al. Effects of recombinant alpha-2b-interferon therapy in patients with progressive MS. Acta. Neurol Scand 1993; 87(6): 457-60.
7. Durelli L, Cocito D, Riccio A, Barile C, Bergamasco B, Baggio GF, et al. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations. Neurology 1986; 36(2): 238-43.
8. Caputo D, Zaffaroni M, Ghezzi A, Cazzullo CL. Azathioprine reduces intrathecal IgG synthesis in multiple sclerosis. Acta Neurol Scand 1987; 75(2): 84-6.
9. Sipe JC, Romine JS, Koziol JA, McMillan R, Zyroff J, Beutler E. Cladribine in treatment of chronic progressive multiple sclerosis. Lancet 1994; 344(8914): 9-13.